Nelly A. Kuklin
Sirna Therapeutics
a wholly owned subsidiary of Merck and Co Inc.
1700 Owens St.
4th Floor
Name/email consistency: high
- RNA-Induced Silencing Complex-Bound Small Interfering RNA Is a Determinant of RNA Interference-Mediated Gene Silencing in Mice. Wei, J., Jones, J., Kang, J., Card, A., Krimm, M., Hancock, P., Pei, Y., Ason, B., Payson, E., Dubinina, N., Cancilla, M., Stroh, M., Burchard, J., Sachs, A.B., Hochman, J.H., Flanagan, W.M., Kuklin, N.A. Mol. Pharmacol. (2011)
- Real-time monitoring of bacterial infection in vivo: development of bioluminescent staphylococcal foreign-body and deep-thigh-wound mouse infection models. Kuklin, N.A., Pancari, G.D., Tobery, T.W., Cope, L., Jackson, J., Gill, C., Overbye, K., Francis, K.P., Yu, J., Montgomery, D., Anderson, A.S., McClements, W., Jansen, K.U. Antimicrob. Agents Chemother. (2003)
- alpha(4)beta(7) independent pathway for CD8(+) T cell-mediated intestinal immunity to rotavirus. Kuklin, N.A., Rott, L., Darling, J., Campbell, J.J., Franco, M., Feng, N., Müller, W., Wagner, N., Altman, J., Butcher, E.C., Greenberg, H.B. J. Clin. Invest. (2000)